Leptin: A new growth factor for the small intestine

被引:31
作者
Alavi, K
Schwartz, MZ
Prasad, R
O'Connor, D
Funanage, V
机构
[1] Alfred I duPont Hosp Children, Dept Surg, Wilmington, DE 19806 USA
[2] Alfred I duPont Hosp Children, Musculoskeletal Inherited Dis Labs, Wilmington, DE 19806 USA
[3] Washington Hosp Ctr, Washington, DC 20010 USA
关键词
leptin; small intestine; short bowel syndrome; growth factor; intestinal absorption;
D O I
10.1053/jpsu.2002.30805
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose: This study was designed to evaluate the potential growth factor effects of systemic administration of leptin on mucosal mass and absorptive function in normal rat intestine. Methods: Twenty male Sprague-Dawley rats underwent placement of a jugular venous catheter connected to a subcutaneous osmotic pump designed to deliver its contents at a constant rate. The rats were divided into 4 groups (n=5 per group) based on the contents of the osmotic pump: group 1, 0.1% bovine serum albumin; group 2, leptin, 6.25 mug/kg/d; Group 3, leptin, 18.75 mug/kg/d; Group 4, leptin, 43.75 mug/kg/d. After a 14-day infusion, [C-14] galactose and [C-14] glycine absorption were determined using a closed, recirculation technique. DNA content was determined from mucosal biopsies. Total RNA was extracted from mucosal samples, reverse transcribed, and amplified via polymerase chain reaction for the following primer pairs: sodium/glucose cotransporter (SGLT-1), fructose transporter (GLUT-5), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, internal standard). Statistical analysis was performed by analysis of variance and expressed as mean +/- SEM. Results: Systemic administration of increasing doses of leptin enhanced DNA content when compared with the appropriate control (group 2, 1.06+/-0.04 [P<.05]; group 3, 1.1±0.05 [P<.01]; and group 4, 1.07+/-0.06 [P<.05]. Leptin enhanced mucosal absorptive function (galactose: group 2, 2.31±0.15 [P<.01]; group 3, 2.71+/-0.06 [P<.01]; group 4, 2.19±0.28 [P<.05]; glycine: group 2, 2.34+/-0.31 [P<.05]; group 3, 3.32±0.14 [P<.01]; group 4, 3.1+/-0.27 [P<.01]) in the normal intestine when compared with the appropriate control animals. Also, leptin enhanced the gene expression of the carbohydrate transporters when compared with the appropriate control rats. Conclusions: These data show that systemic leptin administration enhances mucosal mass and absorptive function in normal rat intestine. Thus, leptin appears to be a growth factor for normal small intestine and may play a role in patients who acquire intestinal dysfunction. J Pediatr Surg 37:327-330. Copyright (C) 2002 by W.B. Saunders Company.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 19 条
  • [1] Interleukin-11 enhances small intestine absorptive function and mucosal mass after intestinal adaptation
    Alavi, K
    Prasad, R
    Lundgren, K
    Schwartz, MZ
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2000, 35 (02) : 371 - 374
  • [3] AN IMPROVED DIPHENYLAMINE METHOD FOR ESTIMATION OF DEOXYRIBONUCLEIC ACID
    GILES, KW
    MYERS, A
    [J]. NATURE, 1965, 206 (4979) : 93 - &
  • [4] Placental leptin: An important new growth factor in intrauterine and neonatal development?
    Hassink, SG
    deLancey, E
    Sheslow, DV
    SmithKirwin, SM
    OConnor, DM
    Considine, RV
    Opentanova, I
    Dostal, K
    Spear, ML
    Leef, K
    Ash, M
    Spitzer, AR
    Funanage, VL
    [J]. PEDIATRICS, 1997, 100 (01) : art. no. - e1
  • [5] Leptin: its pharmacokinetics and tissue distribution
    Hill, RA
    Margetic, S
    Pegg, GG
    Gazzola, C
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (08) : 765 - 770
  • [6] Kato Y, 1999, J PEDIATR SURG, V34, P18, DOI 10.1016/S0022-3468(99)90221-X
  • [7] Enhancement of intestinal adaptation by hepatocyte growth factor
    Kato, Y
    Yu, DH
    Schwartz, MZ
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1998, 33 (02) : 235 - 239
  • [8] Hepatocyte growth factor enhances intestinal mucosal cell function and mass in vivo
    Kato, Y
    Yu, DH
    Lukish, JR
    Schwartz, MZ
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (07) : 991 - 994
  • [9] Hepatocyte growth factor up-regulates SGLT1 and GLUT5 gene expression after massive small bowel resection
    Kato, Y
    Yu, DH
    Schwartz, MZ
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1998, 33 (01) : 13 - 15
  • [10] Influence of luminal hepatocyte growth factor on small intestine mucosa in vivo
    Kato, Y
    Yu, DH
    Lukish, JR
    Schwartz, MZ
    [J]. JOURNAL OF SURGICAL RESEARCH, 1997, 71 (01) : 49 - 53